Rafferty Asset Management, LLC Longboard Pharmaceuticals, Inc. Call Options Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LBPH
# of Institutions
62Shares Held
23.4MCall Options Held
28.9KPut Options Held
13.9K-
Price T Rowe Associates Inc Baltimore, MD2.91MShares$174 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1MShares$60.3 Million0.3% of portfolio
-
Siren, L.L.C. New York, NY903KShares$54.2 Million1.5% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ627KShares$37.6 Million0.07% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $815M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...